⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact SueWallSt
globenewswire.com
REGN
COPD Treatment Landscape Expands, Yet Significant Gaps in Disease Control and Access Persist, According to Spherix Global Insights
globenewswire.com
REGN
MRK
AMGN
REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Deadline
globenewswire.com
REGN
MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law
globenewswire.com
REGN
Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action - Contact Levi & Korsinsky
accessnewswire.com
REGN
ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents
globenewswire.com
ALGT
PHG
MASS
WMT
MDLZ
SSTK
SMCI
NVDA
MSFT
GOOG
AMZN
META
IBM
CRM
ADBE
INTC
AMD
MU
QCOM
PANW
SNPS
CDNS
ASML
AMAT
LRCX
KLAC
TER
NXPI
ON
AEHR
PLTR
AI
UPST
SOFI
COIN
MARA
RIOT
PLUG
FCEL
BE
EXAS
REGN
GILD
BIIB
CRSP
ROKU
NFLX
DIS
CMCSA
TTD
SNOW
DDOG
ZS
CRWD
OKTA
SMTC
MCHP
ADI
TXN
MRVL
ALGN
CTAS
PAYX
ADP
CVS
UNH
AMGN
LLY
PFE
MRK
JNJ
BMY
ABBV
VRTX
AZN
NVO
SNY
XOM
CVX
SRE
NEE
DUK
SO
PCG
ED
AEP
ETR
WEC
D
NI
EXC
NRG
CEG
IRBT
GOOGL
REGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Graft Versus Host Disease (GvHD) Market & Epidemiology Forecast 2026-2036 - Set to Reach New Growth Milestones Through 2036 as Targeted, Cell-Based, and Microbiome Therapies Advance
globenewswire.com
ABBV
JNJ
SNY
INCY
SNDX
NVS
BMY
MRK
REGN
GILD
AMGN
BIIB
AZN
Assessment of the Rheumatoid Arthritis Market 2026-2036 Featuring Rise Therapeutics, Taiho Pharmaceutical, Abbvie, Eli Lilly/Incyte, and AstraZeneca
globenewswire.com
ABBV
LLY
INCY
AZN
REGN
SNY
PFE